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Pathologic Changes Following Chronic
Exposures to Halothane: A Review
by Louis W. Chang*
The toxic effects of halothane on the liver, kidney, and brain are reviewed. Increasing evidence has
indicated that hepatic degeneration can be induced in several animal species after exposure to halothane.
Recent electron microscopic investigations have also revealed cytological degeneration of the liver cells
after chronic exposure to subclinical levels of halothane. Degeneration of the kidney and the nervous
system after halothane exposure have also been reported. The pathological effects of halothane on the
neonatal (developing) liver, kidney, and brain are also demonstrated by electron nicroscopy. Although
the full significance of these observations on experimental animals in relationship to human exposure is
still not known, the indication of the toxic potential of halothane on the biological system is strong and
deserves further investigation.
Since its introduction in 1956 for clinical use (1),
halothane or fluothane (1,1,1-trifluoro-2,2-chloro-
bromoethane) has gained considerable popularity as
an anesthetic agent because it gives the anesthetist
for the first time a controllable, potent, non-
explosive, and nonflammable agent which can be
used with oxygen and nitrous oxide. Despite its
popularity, isolated cases of hepatitis following
exposure to halothane have been reported in medi-
cal literature (2-5), suggesting the possible role of
halothane in the induction of hepatic injury. The
controversy over the existence of halothane
hepatitis has been reviewed by various inves-
tigators (6-8), and halothane hepatitis has been gen-
erally accepted as a medical entity (7). Recent
studies have demonstrated thathepatic lesions simi-
lar to those in human cases could be induced in rats
(9-11) and in guinea pigs (12) after single or re-
peated exposure to halothane, further confirming
the hepatotoxicity of halothane.
Besides the biohazard of halothane towards the
patients, a nationwide epidemiologic survey by a
panel of scientists indicates that chronic exposure
to trace amounts ofanesthetics in the ambient air of
the operating room may also constitute apotentially
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hazardous condition for the operating room person-
nel (13). It was also indicated that such an exposure
may be related to increased frequency of cancer,
liver disease, spontaneous abortion, and congential
abnormalities among OR personnel (13-18).
Only recently have reports appeared document-
ing the concentration of anesthetic agents in the vi-
cinity of the anesthetist in the operating room
(19-22). Linde and Bruce reported peak concentra-
tions of 50 ppm halothane around the anes-
thesiologist (19), while Askrog and Peterson indi-
cated that up to 85 ppm halothane was detected
near the anesthesiologist when a nonrebreathing
system was used (23). In modern, well ventilated
operating rooms, 5-15 ppm halothane could still be
detected in the ambient air of the operating room
(21-25). Increased concern was generated in the ef-
fects of chronic exposure to low levels of anes-
thetics, in particular, halothane (13, 18, 19, 21,
25-35).
Numerous investigations have been performed
in the attempt of providing pathological or mor-
phological evidences of halothane toxicity. These
informations and reports are published at various
times and in different scientific journals. The pur-
pose of the present review paper is to provide a
general overview and summary on the representa-
tive pathological findings in the liver, kidney, and
brain, as a result ofexposure to halothane. Specific
information on each investigation should be con-
sulted with the original articles.
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Because ofthe controversy concerning the ability
of halothane in the induction of hepatic necrosis, a
pathology panel was formed by the National Insti-
tute of Health and National Institute of General
Medical Sciences to investigate the pathological
findings of halothane hepatitis. A report of their
findings was published later (36). It was found that
the hepatic necrosis in most cases has no consistent
pattern, varying from minor focal lesions with
either random or regular zonal distribution to total
parenchyma destruction. In some cases, however,
the necrosis tended to orient about the centrilobular
vein. Qizilbash has recently reviewed five cases of
hepatocellular injury following halothane anes-
thesia (37). Four of the patients had received multi-
ple exposures to the anesthetic, and three of them
died from massive hepatic necrosis (37).
Ultrastructural studies on hepatitis induced by
short-term and acute exposures to halothane have
been performed in both human cases and in animal
models (38-45). The general pathological changes
consisted of swelling and necrosis of the liver cells,
especially in central zones, with inflammatory infil-
trate. The liver cells appeared dark and shrunken in
some areas, swollen and pale in others. Active
parenchymal hepatitis with foci of hepatocellular
necrosis and cytoplasmic reticulum and bil cana-
liculi, mitochondrial changes, and myelin-figure
formation were found in some cases indicating de-
finitive cytological changes in the hepatocytes.
In a recent study, Stevens et al. compared the
toxicities of halothane, isoflurane, and diethyl ether
at subanesthetic concentrations in mice, rats, and
guinea pigs (46). It was found that after 35 days
exposure, halothane produced a greater decrement
in weight gain and a greater incidence of hepatic
degenerative changes than isoflurane of diethyl
ether despite its administration at lower anesthetic
concentrations (0.005-0.03%). Chang et al., by
means of electron microscopy, further demon-
strated cellular changes (such as degeneration ofthe
mitochondria, endoplasmic reticulum, and bile
canaliculi) in the liver of rats (Figs. I and 2) which
were exposed to subclinical level of halothane
5f. ir
' "
, ,..a e, Q t'x b4 t 1 0wS*
w @s&{ .s { C# .<,frV,i. ;ae E
F ~~ ~ -~*~6' ~ ~ ~L. ~ ~. . m l' U
FIGURE 1. Liver, adult rat, 10 ppm halothane, 8 weeks. Mitochondria ofthe hepatocytes appear to be condensed and ofirregular shape.
Increase of cytoplasmic density of hepatocyte is also evident indicating cellular injury. x 9.158.
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FIGURE 2. Liver, adult rat, 500 ppm halothane, 4 weeks. Severe dilatation ofthe bile canaliculi (BC) with peribiliary accumulation of
lysosomes. x 12,753.
(10-500 ppm) for 4-8 weeks (11). When pregnant
rats were exposed to halothane gas under similar
conditions, degenerative changes (such as fatty
changes, leukocytic infiltration, accumulation of
lysosome, and cellular necrosis) were also observed
in the livers of the offspring (34) (Figs. 3 and 4).
Despite increasing evidence indicating that
halothane is hepatotoxic, incidence of fully recog-
nizable hepatic necrosis in human patients follow-
ing halothane anesthesis is very low (47). However,
Stevens et al. have cautioned that perhaps the ex-
tent of hepatic injury following halothane anes-
thesia in man is not as rare as the incidence of mas-
sive hepatitis would suggest (46). They point out
that an elevation of SGPT was frequently found in
patients following halothane anesthesia. Moreover,
prolonged elevations of sulfobromophthalein reten-
tion was found in volunteers subjected to halothane
anesthesia than with isoflurane. These findings
would indicate that a mild hepatic injury is not re-
ally uncommon following halothane anesthesia (46).
At least two explanations have been suggested
for the hepatotoxic effects of halothane. It was sug-
gested that since granuloma formation and
eosinophilia are sometimes associated with
halothane hepatitis (37), hypersensitivity may un-
derlie the pathogenic mechanism of halothane
hepatitis (48-55). A sensitivity phenomenon of
antibody-antigen type could occur if a hapten is
formed by conjugation of the liver protein to the
halothane molecule, or a metabolite ofit. However,
increasing evidence has indicated that halothane, or
its metabolite, probably has a direct hepatotoxic ef-
fect on the liver. Damage to liver cells following
halothane exposure in dogs (56), mice (46, 57),
guinea pigs (12, 46), and rats- (9-11, 34, 36, 58) have
been reported. It is believed that, as in the case of
some other volatile anesthetics such as chloroform
or some other halogenated compounds such as car-
bon tetrachloride, there may be a toxic intermediate
December 1977 197FIGURE 3. Liver, neonatal rat, 10 ppm halothane through pregnancy. Fatty changes and extensive necrosis ofthe hepatocytes (NC) are
observed. x 4,409.
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FIGURE 4. Liver, neonatal rat, 10 ppm halothane through pregnancy. Infiltration of leukocytes (Leuk) is evident. x 5,766.
198 Environmental Health Perspectivesmetabolite which accumulates within the biological
tissues (7, 59). Cohen and Hood revealed an ac-
cumulation of metabolites from volatile anesthetics
such as halothane (60, 61), but these metabolites
were tissue bound to the cell constituents and were
not extractable at the present time. Ofinterest from
a chronic low dose exposure point of view is the
fact that the hepatic halothane metabolism is
concentration-dependent (62). More metabolism
and breakdown ofhalothane occurred in the liverof
subjects who were exposed to lower concentration
of the agent. If the metabolites of halothane are
responsible for liver damage, chronic exposure to
low levels of halothane would then be more toxic
than acute exposures.
Pathological Effects on the
Kidney
It has been claimed that some fluorinated
anesthetics, methoxyfluorane in particular (63-71),
are nephrotoxic. The nephrotoxicity is largely at-
tributed to the accumulation ofinorganic fluoride in
the renal tubules (67, 68, 70, 72, 73). Although there
are no known reports ofhigh-output renal failure in
anesthetists, it is interesting that Bruce et al. re-
ported atwofold increase in chronic renal disease as
a cause of death among anesthetists in the period
from 1957 to 1%6 over the period from 1947 to 1956
(74). It was during the latter 10-year period that the
fluorinated anesthetic agents were introduced.
Halothane must be considered a possible nephro-
toxic agent because it is a fluorinated compound.
However, because there was no significant altera-
tion in the renal function of human volunteers who
were subjected to short-term exposures to acute
doses of methoxyfluorane and halothane (75), no
histologic or cytologic studies of the kidney were
performed.
In a recent report (32), the renal changes follow-
ing chronic exposure to halothane was demon-
strated by electron microscopy. Adult rats which
were exposed to 10-500 ppm halothane for 4-8
weeks demonstrated tubular lesions (proximal con-
voluted tubules, PCT) in the kidney. Degeneration
of the mitochondria, forming large membranous
bodies, were frequently found (Fig. 5). Accumula-
tion of atypical lysomes was also observed in the
proximal tubular epithelial cells (32) (Fig. 6). Simi-
.4~~~~~~~~~~
S<ollj 'R ~ ~~~~ ,.d
FiGuRE 5. Kidney, adult rat, 500 ppm halothane 4 weeks. Extensive accumulation ofmembraneous bodies, presumably derived from
degenerated mitochondria, within an epithelial cell ofthe proximal tubule. x 19,537.
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FIGURE 6. Kidney, adult rat, 500 ppm halothane, 4 weeks. Accumulation ofatypical lysosomes (appear to be irregular dense bodies,
presumably through tusion oflysosomes) within an epithelial cell of the proximal tubule. x 19,537.
lar changes of the lysomes have been reported in
methoxyflurane nephropathy (68), choline-deficient
rats (76), manganese-deficient mice (77), and in
mice with Chediak-Higashi syndrome (78). It has
been proposed that these abnormal lysosomal struc-
tures might be directly related to an alteration in the
lysosomal functions (78).
Besides the mitochondrial and lysosomal
changes, accumulation of spherical particles in the
basement membrane (Fig. 7) extrusion of large
cytoplasmic masses (exocytosis) into the tubular
lumen (Fig. 8) aggregation of smooth endoplasmic
reticulum, and swirling of the basal plasma mem-
brane (Fig. 9) were also observed in the PCT ofthe
kidney (32). The occurrence ofclusters ofspherical
microparticles within the basement membrane as
well as the exocytosis ofcytoplasmic material have
been described in both human and animal kidneys
under diseased situations (79-82). It is believed that
these phenomena represent discharge or extrusion
of cellular debris and material from injured cells.
The formation of smooth endoplasmic reticulum
aggregates (hyperplastic hypoactive endoplasmic
reticulum), the swirling ofbasal plasma membrane,
however, may only represent a "normal" detoxifi-
cation and compensatory response of the kidney
towards the halothane toxicity and its effects ofthe
transport system of the cell membrane (83).
Chang and co-workers further reported the
pathological changes in the neonatal kidneys from
newborn rats which subjected to prenatal exposure
to low levels (10 ppm) of halothane (33). General
degenerative changes such as mitochondria swell-
ing (Fig. 10), accumulation of lysosomes and lipid
droplets (Fig. 11), and enlargement of the apical
vacuoles (Fig. 12) were observed. These degenera-
tive changes were found to be confined to the prox-
imal convoluted tubules only. Massive cellular
casts and cytoplasmic materials were also found
within the tubular lumen indicating tubular injury.
Pathological Effects
on the Nervous System
Three reports in the European literature suggest
headaches and irritability in anesthetists as occupa-
tional hazards (14, 84, 85), possibly attribute to the
direct effects of the agent on the brain or cerebral
vessels. A survey of Russian anesthetists indicates
an increase in functional disturbances ofthe central
Environmental Health Perspectives
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FIGURE7. Kidney, adult rat, 500 ppm halothane, 4 weeks. Accumulation ofspherical microparticles (SMP) inthe basement membrane
(BM) ofthe proximal tubules. x 28,491.
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FIGURE 8. Kidney, adult rat, 500 ppm halothane, 4 weeks. Extension oflarge cytoplasmic masses (CM) and organelles into the tubular
lumen. x 5,766.
December 1977 201FIGURE 9. Kidney, adult rat, 500 ppm halothane, 4 weeks. Swirling ofthe basal infoldings (plasma membrane) ofthe epithelial cells in
the proximal tubules. x 12,753.
FIGURE 10. Kidney, neonatal rat, 10 ppm halothane through pregnancy. A degenerative tubule with much lysosomes and swollen
mitochondria (M). x 5,766.
202 Environmental Health PerspectivesFIGURE 11. Kidney, neonatal rat, 10 ppm halothane through pregnancy. Accumulation of lipid droplets at the basal portion of the
epithelial cells of the proximal tubules. x 12,753.
FIGURE 12. Kidney, neonatal rat, 10 ppm halothane through pregnancy. Enlargement of the apical vacuoles (AV) in the proximal
epithelial cell. x 12,753.
December 1977 203system following prolonged exposure to poorly ven-
tilated operating rooms (14). Various investigators
(20, 86, 87) also indicated that acute exposure to
subanesthetic concentrations of anesthetics pro-
duces temporary deficits in a variety of human be-
havioral function, including memory, mood, and
psychomotor impairment.
Due to its small molecular size and high lipid sol-
ubility, halothane as well as other anesthetics, read-
ily transfers across the blood-brain barrier (88). An
autoradiographic study (89) indicated that halo-
thane is distributed to the cerebral cortical gray
matter rapidly during exposure. Despite the known
physiological effects of halothane on the nervous
system (90), little investigation has been performed
to study any morphological changes in the nerve
cells following exposure to halothane.
It is not until in a recent report (29) that the in-
formation concerning the morphological changes in
the brain as a result of halothane exposure was
made available. Chang and co-workers described
that as a result of chronic exposure (4-8 weeks) to
low levels (10-500 ppm) of halothane, degeneration
changes such as severe vacuolation of the Golgi
complex (Figs. 13 and 14) and collapse ofthe rough
ur in - - WIV4w. - '. t
endoplasmic reticulum (RER) (Fig. 15) could be
observed in some cortical neurons of the rat brain
(29). The significance of the Golgi vacuolation is
still not fully understood. However, the disruption
of the RER certainly denoted a dysfunction ofpro-
tein synthesis in these neurons. Neuronal death was
also occasionally observed. Chang and co-workers
(30) further reported degenerative changes in the
cortical neurons of neonatal rats which were pre-
natally exposed to halothane (pregnant animals
were exposed to 10 ppm halothane during preg-
nancy). Degeneration of the Golgi complex was
again a prominent pathological feature (Figs. 16 and
17). Weaking and focal disruption of the neuronal
nuclear membrane (Figs. 18 and 19) was also a fre-
quent finding. Such lesions may lead to eventual
cell deaths. Accumulation of cytoplasmic debris
and lysosomes could still be observed within some
neuronal processes and macrophages (Fig. 20) in
100-day-old rats which were subjected to prenatal
halothane exposure indicating that the damage to
the nerve cells in these animals by halothane or its
metabolite is a-n unduring one. Learning deficits in
rats which were exposed to halothane during early
life has been reported (35). Such finding further
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FIGURE 13. Cerebral cortex, adult rat, 500 ppm halothane, 4 weeks. Degradation ofthe neuronal Golgi complex (G) is seen. x 19,537.
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204FIGURE 14. Cerebral cortex, adult rat, 500 ppm halothane, 4 weeks. Extensive degradation and vacuolation ofthe Golgi complex (G).
x 19,537.
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FiGuRE 15. Cerebral cortex, adultrat, 500 ppm halothane, 4 weeks. Collapse ofthe rough endoplasmic reticulum (RER). No ribosome
is observed on the collapsed portion ofthe endoplasmic reticulum. x 39,142.
December 1977 205FiGuRE 16. Cerebral cortex, neonatal rat, 10 ppm halothane through pregnancy. Dissolution of the Golgi complex (G) in a neuron.
x 19,537.
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FIGURE 17. Cerebral cortex, neonatal rat, 10 ppm halothane through pregnancy. Dilation and vacuolation of the neuronal Golgi complex (G) x 19,537.
206 Environmental Health PerspectivesFIGURE 18. Cerebral cortex, neonatal rat, 10 ppm halothane through pregnancy. Weakening and out-pouching ofthe neuronal nuclear
membrane (x*). x 28,627.
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FIGURE 19. Cerebral cortex, neonatal rate, 10 ppm halothane through pregnancy. Myelin-figure formation by the neuronal nuclear
envelop ( ). x 28,627.
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FIGURE 20. Cerebral cortex, adult rat, 10 ppm halothane inuteral exposure. Degenerative products are still observable in some
macropheyes. x 19,537.
supports the concept that halothane may exert an
undesirable effect on the developing nervous sys-
tem.
Concluding Remarks
The present review represents an overview ofthe
pathological findings in the liver, kidney, and ner-
vous system ofthe adult and neonatal rats following
chronic exposure to low levels of halothane. From
all the information collected to date, one may con-
clude that halothane could have a direct cellular
toxicity. In view of the various pathological in-
volvements (mitochondria, plasma membrane,
Golgi couplex, endoplasmic reticulum etc.) it ap-
pears that the biological membrane system could be
one of the prime targets of action by halothane.
Since all the present observations were based on
laboratory animals under experimental conditions,
direct extrapolation ofthese findings to human situ-
ations may be overly hasty at this time. These find-
ings should only serve as an indication and basis for
further studies on the effects of halothane or the
biological system and human subjects.
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